Skip to main content
Clinical Trials/NCT03932396
NCT03932396UnknownNot Applicable

A Novel Hepatitis c micrOelimination Program in Non imprisonEd SenTenced With Alternative Measures

Instituto de Investigación Marqués de Valdecilla1 site in 1 country1,000 target enrollmentStarted: May 10, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
1,000
Locations
1
Primary Endpoint
Number of subjects screened for anti-HCV

Study Overview

Brief Summary

The objective of this study is to carry out a Micro-elimination program for HCV infection in a vulnerable population (people sentenced to non-custodial sentences). This group shares certain peculiarities with the prison population (vulnerability, addictions, mental disorders, etc.), is three times higher than the imprisoned population, and is regularly attended by Social Insertion Centers (CIS) in Spain. An additional objective is to link these people with the specific plans of the Government of Cantabria (Chronicity Plan, Care for Serious Mental Disorders, Harm Reduction Programs and the Center for Attention to Drug Addicts) as well as the Extended Bridge Program for Penitentiary Institutions, implementing the figure of a Navigator (a specialized professional in charge of helping subjects overcome barriers). It is an observational study based on the screening of disease in accordance with the recommendations of the health authorities. Once detected, patients will be referred to the corresponding specialized care following the usual clinical practice.

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 79 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •the entire population served in the Management of Penalties and Alternative Measures Service (SGPMA) of the José Hierro SIC, including new admissions within the study period.

Exclusion Criteria

  • •they are not willing to participate and do not sign informed consent.

Outcomes

Primary Outcomes

Number of subjects screened for anti-HCV

Time Frame: From march of 2019 to march of 2021

Percentage of anti-HCV positive

Time Frame: From march of 2019 to march of 2021

Number of subjects screened for drug addiction

Time Frame: From march of 2019 to march of 2021

Percentage of subjects linked to the Extended Bridge program of Penitentiary Institutions

Time Frame: From march of 2019 to march of 2021

Number of anti-HCV positive subjects with detectable viremia

Time Frame: From march of 2019 to march of 2021

Percentage of subjects with detectable viremia

Time Frame: From march of 2019 to march of 2021

To detect other comorbidities such as mental disorders, drug dependencies in this population and link these patients with specific health care programs of Penitentiary Institutions (Extended Bridge Program) and the Government of Cantabria (Chronicity and

Time Frame: From march of 2019 to march of 2021

Number of subjects screened for mental illness.

Time Frame: From march of 2019 to march of 2021

Percentage of subjects with mental illness

Time Frame: From march of 2019 to march of 2021

Number of subjects with an average rating greater than 4 on a Likert scale of 5 points of satisfaction with the Navigator

Time Frame: From march of 2019 to march of 2021

Percentage of subjects with drug addiction

Time Frame: From march of 2019 to march of 2021

Percentage of subjects linked to the Chronicity Program of the Government of Cantabria

Time Frame: From march of 2019 to march of 2021

Number of subjects linked to the Chronicity Program of the Government of Cantabria

Time Frame: From march of 2019 to march of 2021

Number of subjects linked to the Extended Bridge program of Penitentiary Institutions

Time Frame: From march of 2019 to march of 2021

Number of subjects served by the Navigator

Time Frame: From march of 2019 to march of 2021

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Instituto de Investigación Marqués de Valdecilla
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials